193 related articles for article (PubMed ID: 1503891)
1. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
3. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
4. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
[TBL] [Abstract][Full Text] [Related]
6. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
8. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
[TBL] [Abstract][Full Text] [Related]
9. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
Daniel PT; Krammer PH
J Immunol; 1994 Jun; 152(12):5624-32. PubMed ID: 7515909
[TBL] [Abstract][Full Text] [Related]
10. Human tonsil implants xenotransplanted in SCID mice display broad lymphocytic diversity and cellular activation profile similar to those in the original lymphoid organ.
Vallet V; Mauray S; Kindler V; Aubry D; Ruegg M; Cherpillod J; Waridel F; Schapira M; Duchosal MA
Xenotransplantation; 2005 Jan; 12(1):38-48. PubMed ID: 15598272
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
12. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of specific immunoglobulin production in SCID-hu-PBL mice after in vitro priming of human B cells with superantigen.
Mårtensson C; Ifversen P; Borrebaeck CA; Carlsson R
Immunology; 1995 Oct; 86(2):224-30. PubMed ID: 7490122
[TBL] [Abstract][Full Text] [Related]
14. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.
Murphy WJ; Funakoshi S; Fanslow WC; Rager HC; Taub DD; Longo DL
Clin Immunol; 1999 Jan; 90(1):22-7. PubMed ID: 9884349
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific IgG responses from naive human splenocytes: in vitro priming followed by antigen boost in the SCID mouse.
Brams P; Nguyen ML; Chamat S; Royston I; Morrow PR
J Immunol; 1998 Mar; 160(5):2051-8. PubMed ID: 9498740
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human IgE response in hu-PBL-SCID mice.
Kilchherr E; Mandak V; Wagner K; Heusser CH
Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the adoptive transfer of delayed hypersensitivity and T cell repertoire in severe combined immunodeficiency mice reconstituted with human lymphocytes.
Mancia L; Mariani F; Mattei M; Montesano C; Placido R; Colizzi V; Salerno A; Bellavia A
Folia Biol (Praha); 1994; 40(6):411-30. PubMed ID: 7589700
[TBL] [Abstract][Full Text] [Related]
18. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
19. Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells.
Jarman ER; Perschke K; Montermann E; Herz U; Renz H; Knop J; Reske-Kunz AB
J Allergy Clin Immunol; 2000 May; 105(5):967-74. PubMed ID: 10808178
[TBL] [Abstract][Full Text] [Related]
20. The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice.
Walker W; Gallagher G
Immunology; 1994 Oct; 83(2):163-70. PubMed ID: 7530687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
